Maze Therapeutics, Inc. (MAZE)

Maze Therapeutics Statistics

Total Valuation

MAZE has a market cap or net worth of $1.42 billion. The enterprise value is $1.09 billion.

Market Cap	1.42B
Enterprise Value	1.09B

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026, after market close.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

MAZE has 55.25 million shares outstanding. The number of shares has increased by 1,474.04% in one year.

Current Share Class	55.25M
Shares Outstanding	55.25M
Shares Change (YoY)	+1,474.04%
Shares Change (QoQ)	+16.64%
Owned by Insiders (%)	1.09%
Owned by Institutions (%)	55.19%
Float	27.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	120.86
PB Ratio	3.61
P/TBV Ratio	3.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 15.50, with a Debt / Equity ratio of 0.07.

Current Ratio	15.50
Quick Ratio	15.23
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -47.52% and return on invested capital (ROIC) is -510.00%.

Return on Equity (ROE)	-47.52%
Return on Assets (ROA)	-28.01%
Return on Invested Capital (ROIC)	-510.00%
Return on Capital Employed (ROCE)	-38.15%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$929,929
Employee Count	141
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +168.38% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+168.38%
50-Day Moving Average	38.85
200-Day Moving Average	31.80
Relative Strength Index (RSI)	28.88
Average Volume (20 Days)	1,049,094

Short Selling Information

The latest short interest is 3.89 million, so 7.04% of the outstanding shares have been sold short.

Short Interest	3.89M
Short Previous Month	3.59M
Short % of Shares Out	7.04%
Short % of Float	14.05%
Short Ratio (days to cover)	3.35

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-142.90M
Pretax Income	-131.12M
Net Income	-131.12M
EBITDA	-140.50M
EBIT	-142.90M
Earnings Per Share (EPS)	-$3.05

Balance Sheet

The company has $341.92 million in cash and $23.31 million in debt, with a net cash position of $318.61 million or $5.77 per share.

Cash & Cash Equivalents	341.92M
Total Debt	23.31M
Net Cash	318.61M
Net Cash Per Share	$5.77
Equity (Book Value)	354.97M
Book Value Per Share	7.20
Working Capital	327.16M

Cash Flow

In the last 12 months, operating cash flow was -$111.94 million and capital expenditures -$794,000, giving a free cash flow of -$112.73 million.

Operating Cash Flow	-111.94M
Capital Expenditures	-794,000
Depreciation & Amortization	2.40M
Net Borrowing	n/a
Free Cash Flow	-112.73M
FCF Per Share	-$2.04

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MAZE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,474.04%
Shareholder Yield	-1,474.04%
Earnings Yield	-9.31%
FCF Yield	-8.00%

Analyst Forecast

The average price target for MAZE is $68.25, which is 166.29% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$68.25
Price Target Difference	166.29%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2